Innovation in Medical Technology

Margaret L. Eaton is a lecturer at the Stanford University Graduate School of Business and was formerly a senior research scholar at the Center for Biomedical Ethics, Stanford University School of Medicine. Donald Kennedy is emeritus Bing Professor of Environmental Science and President Emeritus of Stanford University. A former U.S. Food and Drug Administration commissioner, Dr. Kennedy co-chairs the National Academies of Science Project on Science, Technology, and Law and is the editor-in-chief of Science.

Preface
Acknowledgments
Introduction: The Need to Ask Questions about Innovation
1. Distinguishing Innovative Medical Practice from Research
2. The Modern History of Human Research Ethics
3. Innovation in the Off-Label Use of Drugs
4. Innovative Surgery
5. Innovation in Assisted Reproduction
6. Innovation in Neuroimaging
7. Questions, Issues, and Recommendations Going Forward
Conclusion: Final Thoughts on the Landscape of Innovation
Appendix A: Directives for Human Experimentation: Nuremberg Code
Appendix B: World Medical Association Declaration of Helsinki
Appendix C: Description of Department of Health and Human Services
Regulations for the Protection of Human Subjects
Appendix D: Participants in Lasker Forum on Ethical Challenges in Biomedical Research and Practice
Notes
References
Index